606932-79-0

Basic information

• Product Name: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]acrylic acid methyl ester
• Synonyms: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]acrylic acid methyl ester
• CAS NO: 606932-79-0
• Molecular Weight: 418.446
• Mol File: 606932-79-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]acrylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]acrylic acid methyl ester(606932-79-0)
• EPA Substance Registry System: 3-(3,5-dimethoxyphenyl)-2-[4-(4-formylphenoxy)phenyl]acrylic acid methyl ester(606932-79-0)

Safety Data

• Hazardous Substances Data: 606932-79-0(Hazardous Substances Data)

Upstream product

• 459-57-4 4-fluorobenzaldehyde 
• 606932-78-9 3-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)acrylic acid methyl ester 
• 116518-98-0 E-3-(3,5-dimethoxy-phenyl)-2-(4-hydroxy-phenyl)-acrylic Acid 
• 7311-34-4 3,5-dimethoxybenzaldehdye 
• 156-38-7 4-hydroxyphenylacetate 

Downstream Products

• 606932-80-3 methyl (E)-3-(3,5-dimethoxyphenyl)-2-(4-(4-((Z)-(2,4-dioxothiazolidine-5-ylidene)methyl)phenoxy)phenyl)acrylate 
• 606932-82-5 3-(3,5-dimethoxyphenyl)-2-{4-[4-(hydroxymethyl)phenoxy]phenyl}acrylic acid methyl ester 
• 606932-81-4 methyl (E)-3-(3,5-dimethoxyphenyl)-2-(4-(4-((2,4-dioxothiazolidin-5-yl)methyl)phenoxy)phenyl)acrylate 

Relevant articles and documents

Thiazolidinedione derivatives and pharmaceutical compositions containing same

The present invention relates to thiazolidinedione derivatives and pharmaceutical compositions comprising the same. Specifically, the compounds disclosed by the invention have a structure shown as a formula (I), and the definitions of all groups and subst

Novel Heterocyclic analogs of diphenylethylene compounds

Novel diphenylethylene compounds containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes. In co